Erratum: Chemically-Modified Peptides Targeting the PDZ Domain of GIPC as a Therapeutic Approach for Cancer (ACS Chemical Biology (2012) 7:4 (770-779) DOI: 10.1021/cb200536r)

Chitta Ranjan Patra, Chamila N. Rupasinghe, Shamit K. Dutta, Santanu Bhattacharya, Enfeng Wang, Mark R. Spaller, Debabrata Mukhopadhyay

Research output: Contribution to journalComment/debatepeer-review

Abstract

After the publication of this work,1 an apparent error in one of the beta-actin blots (Figure 8d) was brought to our attention. After we reviewed the original gel data, we identified the source of this mistake. It appears that in the submitted manuscript, we had accidently placed the incorrect beta-actin bands in Figure 8d during figure compilation. This has now been corrected in the new Figure 8d. The results and the interpretation of the figure have not changed and do not alter in any way the conclusion of the manuscript. We regret this unintentional error and any inconvenience this may have caused. (Figure Presented).

Original languageEnglish (US)
Pages (from-to)2327
Number of pages1
JournalACS Chemical Biology
Volume14
Issue number10
DOIs
StatePublished - Oct 18 2019

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine

Fingerprint Dive into the research topics of 'Erratum: Chemically-Modified Peptides Targeting the PDZ Domain of GIPC as a Therapeutic Approach for Cancer (ACS Chemical Biology (2012) 7:4 (770-779) DOI: 10.1021/cb200536r)'. Together they form a unique fingerprint.

Cite this